ARTBIO Announces FDA Clearance of IND Application for Lead Alpha Radioligand Therapy AB001
ARTBIO is developing AB001, a Pb212 prostate-specific membrane antigen (PSMA)-targeted radioligand therapy, for the treatment of metastatic castration resistant…